Fingerprint
Dive into the research topics of 'Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion
John G. Kuhn, Daniel D. Von Hoff, Marla Hersh, Theresa Melink, Gary M. Clark, Geoffrey R. Weiss, Charles A. Coltman
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations